A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid Tumours

NCT02182128 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim